In 1978, Cipla started manufacturing of Metered-Dose Inhaler (MDI). 1984 was the year when the company name was changed from The Chemical, Industrial & Pharmaceutical Laboratories to Cipla Limited.

However, over the years, Cipla has reduced its dependence on tenders from 18% in FY17 to low single-digit in FY24 due to competition and low margins. Vohra said it is too early to predict the Trump ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

Drugmaker Cipla expects its “diversified” business in the US to help sustain its growth ... On the new US administration’s possible tariffs on pharmaceuticals, Vohra said, the company had invested ...

A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. Cole Schmidtknecht, 22, suffered from asthma ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.